Effect of fenretinide on plasma IGF-I and IGFBP-3 in early breast cancer patients

International Journal of Cancer

Volumn 76, Issue 6, 1998, Pages 787-790

  Torrisi, R ^a   Parodi, S ^a   Fontana, V ^a   Pensa, F ^a   Casella, C ^a   Barreca, A ^a   De Palo, G ^a   Costa, A ^a   Decensi, A ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FENRETINIDE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; FEMALE; FENRETINIDE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED;

EID: 0032503554     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980610)76:6<787::AID-IJC3>3.0.CO;2-U     Document Type: Article

References (27)